Cellebrite DI Ltd. Provides Revenue Guidance for the Second Quarter and Second Half of 2022
For the second half, the company expects revenue to be higher than first half revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.83 USD | +0.34% | +4.69% | +36.61% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
1st Jan change | Capi. | |
---|---|---|
+36.61% | 2.42B | |
+14.09% | 3,161B | |
+11.00% | 87.62B | |
+6.51% | 79.59B | |
-12.92% | 54.14B | |
+23.70% | 48.15B | |
+32.92% | 47.69B | |
-25.15% | 46.81B | |
+80.89% | 42B | |
-5.92% | 25.77B |